AgeX Therapeutics
NYSE:AGEAgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-related metabolic disorders, such as Type II adult-onset diabetes and obesity; and AGEX-VASC1, a cell-based therapy to restore vascular support in aged ischemic tissues, such as peripheral vascular disease and ischemic heart disease. Its lead small molecule drug-based therapeutic candidate for scarless wound repair in discovery is AGEX-iTR1547, a drug-based formulation; and lead biologic candidate for induced tissue regeneration is AGEX-iTR1550 (Renelon), a gene delivery technology. AgeX Therapeutics, Inc. has a research collaboration with the University of California at Irvine to develop cellular therapies to treat neurological disorders and diseases. The company was incorporated in 2017 and is based in Alameda, California.
Dajin Lithium
CVE:DJIDajin Lithium Corp., together with its subsidiaries, primarily engages in the acquisition, exploration, and development of mineral properties in Canada, the United States, and Argentina. It explores for lithium, potash, and boron minerals. The company holds a 100% interest in Teels Marsh Project that covers 403 placer mineral claims covering an area of approximately 3,202 hectares located in the Teels Marsh valley of Mineral County, Nevada; and Alkali Lake project, which includes 62 placer mineral claims situated in the Alkali Spring valley of Esmeralda county, Nevada. It also holds 49% interests in the Salinas Grandes Salar project that covers an area of 93,000 hectares located in the Jujuy province, Argentina. The company was formerly known as Dajin Resources Corp. and changed its name to Dajin Lithium Corp. in January 2020. Dajin Lithium Corp. was incorporated in 1987 and is based in Vancouver, Canada.
Kenon
NYSE:KENKenon Holdings Ltd., through its subsidiaries, operates as an owner, developer, and operator of power generation facilities in Israel, the United States, and internationally. It operates through OPC Power Plants, CPV Group, and ZIM segments. The company engages in the generation and supply of electricity and energy; development, construction, and management of solar and wind energy, and conventional natural gas-fired power plants; and provision of container liner shipping services. It also operates a fleet of 150 vessels. Kenon Holdings Ltd. was incorporated in 2014 and is based in Singapore. Kenon Holdings Ltd. operates as a subsidiary of Ansonia Holdings Singapore B.V.
Rackla Metals
CVE:RAKRackla Metals Inc., a junior gold exploration company, engages in the acquisition, exploration, and evaluation of mineral properties in Canada. The company holds a 100% interest in the Rivier property located in the Watson Lake Mining District, Yukon. It also holds interests in the Tombstone Gold Belt projects situated in Yukon and Northwest Territories. The company was incorporated in 2011 and is headquartered in Vancouver, Canada.